$59.43
0.210.35%
At close: -
$59.43
0.000.00%
After Hours: 4:00 PM EDT
Rhythm Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Rhythm Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $-0.73 | $-0.80 | 8.75 % |
Q2 | 2024-08-06 | $-0.55 | $-0.71 | 22.5 % |
Q1 | 2024-05-07 | $-2.35 | $-2.16 | -8.80 % |
Q4 | 2024-02-22 | $-0.70 | $-0.70 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $33.25M | $32.52M | 2.25 % |
Q2 | 2024-08-06 | $29.08M | $29.29M | -0.72 % |
Q1 | 2024-05-07 | $25.97M | $26.90M | -3.47 % |
Q4 | 2024-02-22 | $24.23M | $25.38M | -4.52 % |
Rhythm Pharmaceuticals (RYTM) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $-0.73, which beat the estimate of $-0.80.
The Actual Revenue was $33.3M, which beat the estimate of $32.5M.
Browse earnings estimates, EPS, and revenue on all stocks.